RhumbLine Advisers
HITK

RhumbLine Advisers’s HI-TECH PHARMACAL INC HITK Stock Holding History

RhumbLine Advisers’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-17,233
Closed -$747K – 3158
2014
Q1 		$747K Buy
17,233
+50
+0.3% +$2.17K ﹤0.01% 1984
2013
Q4 		$746K Sell
17,183
-145
-0.8% -$6.27K ﹤0.01% 2003
2013
Q3 		$748K Buy
17,328
+671
+4% +$25.7K ﹤0.01% 1962
2013
Q2 		$553K Buy
+16,657
New +$554K ﹤0.01% 2176

RhumbLine Advisers's HITK Position: Q2 2014 in Review

RhumbLine Advisers sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 17,233 shares — an estimated $747K sold.

RhumbLine Advisers first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $748K in Q3 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • RhumbLine Advisers reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • RhumbLine Advisers sold 17,233 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $747K.
  • RhumbLine Advisers first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • RhumbLine Advisers's HI-TECH PHARMACAL INC position peaked at $748K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.